Lamisil
Lamisil is a medicine authorised by Swissmedic under authorisation number 51307. The authorisation holder is Medius AG. The medicinal product code is Synthetic medicines and the dispensing category is D: Supplied in pharmacies and drugstores after specialist advice, without a prescription. First authorisation was granted on 18 September 1991 and the authorisation is valid without a time limit. ATC code D01AE15 places the medicine in the group Antifungals for dermatological use.
| No. | Name | Dispensing category | Authorisation date |
|---|---|---|---|
| 1 | Lamisil, Crème | D | 18 September 1991 |
Scroll the table sideways
| Pack code | Quantity | Unit | ATC | IT code | Dispensing category |
|---|---|---|---|---|---|
| 11 | 15 | g | D01AE15 | 10.09.4. | D |
Scroll the table sideways
Medicines in the same ATC group
Other medicines from this authorisation holder
Frequently asked questions
Is Lamisil authorised in Switzerland?
Yes. Lamisil is authorised by Swissmedic under authorisation number 51307, data as of 01 September 2026. The authorisation is valid without a time limit.
Which dispensing category does Lamisil have?
Lamisil is in dispensing category D. Supplied in pharmacies and drugstores after specialist advice, without a prescription.
Who is the authorisation holder of Lamisil?
The authorisation holder is Medius AG. The holder carries the legal responsibility for quality, safety and product information of the medicine in Switzerland.
Sources
Swissmedic data as of 01 September 2026. No medical advice. Independent directory, not affiliated with Swissmedic or the FOPH.